Literature DB >> 8642343

Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.

M R Weiser1, J P Williams, F D Moore, L Kobzik, M Ma, H B Hechtman, M C Carroll.   

Abstract

Reperfusion of ischemic tissue induces an acute inflammatory response that can result in necrosis and irreversible cell injury to both local vascular endothelium and parenchyma. To examine the pathogenesis of ischemia/reperfusion injury, we have used mice deficient in complement components C3, C4, or serum immunoglobulin in a hindlimb model of ischemia. We found that mice homozygous deficient in C3 or C4 were equally protected against reperfusion injury based on a significant reduction in leakage of radiolabeled albumin out of the vasculature. This demonstrates that classical pathway complement is an important factor in the initiation of inflammation following reperfusion. Furthermore, mice deficient in serum immunoglobulin were equally protected and this protection could be reversed by reconstitution with serum from normal mice. Thus, this report describes a novel mechanism for reperfusion injury that involves antibody deposition and activation of complement leading to inflammation permeability.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642343      PMCID: PMC2192547          DOI: 10.1084/jem.183.5.2343

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear.

Authors:  N B Vedder; R K Winn; C L Rice; E Y Chi; K E Arfors; J M Harlan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 2.  Molecular organization and function of the complement system.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families.

Authors:  I Sanz; P Casali; J W Thomas; A L Notkins; J D Capra
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

4.  Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation.

Authors:  R M Marks; R F Todd; P A Ward
Journal:  Nature       Date:  1989-05-25       Impact factor: 49.962

5.  Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.

Authors:  D Y Leung; T Collins; L A Lapierre; R S Geha; J S Pober
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

Review 6.  Membrane complement receptors specific for bound fragments of C3.

Authors:  G D Ross; M E Medof
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

7.  Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.

Authors:  H Schäfer; D Mathey; F Hugo; S Bhakdi
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

8.  Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.

Authors:  M R Wessels; P Butko; M Ma; H B Warren; A L Lage; M C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

9.  Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardium.

Authors:  F Hugo; T Hamdoch; D Mathey; H Schäfer; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

10.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.

Authors:  H F Weisman; T Bartow; M K Leppo; H C Marsh; G R Carson; M F Concino; M P Boyle; K H Roux; M L Weisfeldt; D T Fearon
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

View more
  113 in total

1.  Complement activation by apoptotic endothelial cells following hypoxia/reoxygenation.

Authors:  C Mold; C A Morris
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

2.  Complement activation promotes muscle inflammation during modified muscle use.

Authors:  J Frenette; B Cai; J G Tidball
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

3.  Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris.

Authors:  R J Quigg; C He; B K Hack; J J Alexander; B P Morgan
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

4.  Analysis of differential immune responses induced by innate and adaptive immunity following transplantation.

Authors:  Hongzhen He; James R Stone; David L Perkins
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

Review 5.  Complement in ischemia reperfusion injury.

Authors:  Niels C Riedemann; Peter A Ward
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

6.  Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury.

Authors:  Ming Zhang; William G Austen; Isaac Chiu; Elisabeth M Alicot; Rachel Hung; Minghe Ma; Nicola Verna; Min Xu; Herbert B Hechtman; Francis D Moore; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

Review 7.  The role of complement in the early immune response to transplantation.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

8.  Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury.

Authors:  Michael R Pope; Urska Bukovnik; John M Tomich; Sherry D Fleming
Journal:  J Immunol       Date:  2012-10-03       Impact factor: 5.422

9.  Mouse mast cell proteases 4 and 5 mediate epidermal injury through disruption of tight junctions.

Authors:  Lora G Bankova; Cecilia Lezcano; Gunnar Pejler; Richard L Stevens; George F Murphy; K Frank Austen; Michael F Gurish
Journal:  J Immunol       Date:  2014-02-12       Impact factor: 5.422

Review 10.  Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury.

Authors:  Emily Archer Slone; Sherry D Fleming
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.